Back
Insight Molecular Diagnostics, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
32
IMDX
Insight Molecular Diagnostics, Inc.
Last Price:
$5.59
Seasonality Move:
13.47%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiInsight Molecular Diagnostics, Inc. Stock Forecast
-
Over the next 52 weeks, Insight Molecular Diagnostics, Inc. has on average historically fallen by 12.9% based on the past 9 years of stock performance.
-
Insight Molecular Diagnostics, Inc. has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Insight Molecular Diagnostics, Inc. Stock Undervalued?The current Insight Molecular Diagnostics, Inc. [IMDX] share price is $5.58. The Score for IMDX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
IMDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Insight Molecular Diagnostics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Insight Molecular Diagnostics, Inc. has on average historically fallen by 12.9% based on the past 9 years of stock performance.
Insight Molecular Diagnostics, Inc. Stock Rating
Sell
32
Insight Molecular Diagnostics, Inc. (IMDX)
is a Sell
Is Insight Molecular Diagnostics, Inc. overpriced?
-
Insight Molecular Diagnostics, Inc. has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Insight Molecular Diagnostics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oncocyte.com
52-Week Data
52-Week High:
8.51
52-Week Low:
1.92
Prediction Charts
Market Cap:
159.9M
Price in USD:
5.58
Volume:
24.1K
Beta:
1.76
Technical Analysis
SMA50:
5.47
SMA100:
4.12
SMA200:
3.60
52-Wk Change:
133.47%
Stock Predictions
-
Is Insight Molecular Diagnostics, Inc. stock public?Yes, Insight Molecular Diagnostics, Inc. is a publicly traded company.
-
What is the Insight Molecular Diagnostics, Inc. stock quote today?The Insight Molecular Diagnostics, Inc. stock price is 5.58 USD today.
-
How to buy Insight Molecular Diagnostics, Inc. stock online?You can buy Insight Molecular Diagnostics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 7.77 | 7.40 | 7.92 | 7.08 |
| Nov-17 | 7.42 | 6.70 | 7.56 | 6.00 |
| Nov-18 | 6.55 | 6.33 | 6.58 | 6.27 |
| Nov-19 | 6.31 | 6.00 | 6.66 | 5.99 |
| Nov-20 | 6.05 | 6.07 | 6.35 | 5.82 |
| Nov-21 | 6.06 | 6.04 | 6.24 | 5.92 |
| Nov-24 | 6.04 | 6.12 | 6.15 | 5.84 |
| Nov-25 | 6.15 | 6.15 | 6.15 | 5.99 |
| Nov-26 | 6.15 | 6.04 | 6.15 | 6.04 |
| Nov-28 | 6.09 | 6.14 | 6.15 | 6.09 |
| Dec-1 | 6.09 | 5.76 | 6.14 | 5.75 |
| Dec-2 | 5.76 | 5.52 | 5.84 | 5.44 |
| Dec-3 | 5.56 | 5.34 | 5.56 | 5.20 |
| Dec-4 | 5.27 | 5.58 | 5.69 | 5.27 |
Insight Molecular Diagnostics, Inc. Earnings
Insight Molecular Diagnostics, Inc. Earnings Report: Per Share Insight Molecular Diagnostics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Insight Molecular Diagnostics, Inc. Forecast Revenue Growth
Insight Molecular Diagnostics, Inc. Stock Analysis: Historical quarterly revenues per share for Insight Molecular Diagnostics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.14 per share.
* Insight Molecular Diagnostics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.